We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Says Minor CMC Changes for Biologics Must Be Documented in Annual Report
FDA Says Minor CMC Changes for Biologics Must Be Documented in Annual Report
Minor changes to a drugmaker’s chemistry, manufacturing and controls (CMC) production processes for approved biologics must be documented in a yearly report, the FDA said in a final guidance released yesterday.